LYMPHOMA, NON-HODGKIN
Clinical trials for LYMPHOMA, NON-HODGKIN explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMA, NON-HODGKIN trials appear
Sign up with your email to follow new studies for LYMPHOMA, NON-HODGKIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug takes aim at Hard-to-Treat blood cancers
Disease control Not yet recruitingThis early-stage trial tests a new drug called LY4152199 in about 215 adults with certain types of blood cancer (like follicular lymphoma or diffuse large B-cell lymphoma) that have already been treated. The drug is designed to help the body's immune cells attack the cancer. The …
Matched conditions: LYMPHOMA, NON-HODGKIN
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New hope for tough lymphoma: experimental drug GSK5926371 enters human trials
Disease control Not yet recruitingThis early-stage trial tests a new drug called GSK5926371 in about 49 adults with B-cell non-Hodgkin lymphoma that has returned or not responded to at least two prior treatments. The main goals are to check the drug's safety and see if it can shrink tumors. Researchers will also …
Matched conditions: LYMPHOMA, NON-HODGKIN
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for lymphoma: immune booster plus chemotherapy trial launches
Disease control Not yet recruitingThis Phase 2 trial tests whether adding epcoritamab, an immune-boosting drug, to standard R-CHOP chemotherapy can safely treat newly diagnosed aggressive B-cell lymphoma. About 20 adults with certain lymphoma types will receive the combination. The main goal is to check for a sid…
Matched conditions: LYMPHOMA, NON-HODGKIN
Phase: PHASE2 • Sponsor: Mwanasha Merrill, MD • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can a vitamin D2 blast speed up recovery in lymphoma patients?
Disease control Not yet recruitingThis study compares a high-intensity loading dose of vitamin D2 to standard weekly dosing in 52 patients with newly diagnosed aggressive non-Hodgkin lymphoma who are also receiving standard chemotherapy. The goal is to see if the high-dose approach normalizes vitamin D levels fas…
Matched conditions: LYMPHOMA, NON-HODGKIN
Phase: NA • Sponsor: Phramongkutklao College of Medicine and Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Healing harmonies: music therapy aims to ease stem cell transplant recovery
Symptom relief Not yet recruitingThis study tests an online music therapy program that combines mindfulness and music to help people recovering from stem cell transplants for blood cancers. Researchers want to see if it can improve quality of life, reduce pain, fatigue, anxiety, and depression, and possibly spee…
Matched conditions: LYMPHOMA, NON-HODGKIN
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC